Aldeyra Therapeutics
ALDX • NASDAQ
Aldeyra Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Todd C. Brady, with a market cap of $106.5M.
CEOTodd C. Brady
Next Earnings
Upcoming earnings announcement for Aldeyra Therapeutics
Date
Wednesday, May 13, 2026 (in a month)
Timing
After Market Close (5:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.12
Revenue Estimate
$47.0M
Earnings History
Past 12 earnings reports for Aldeyra Therapeutics
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 5, 2025 | Q3 2025 | -$0.13Est: -$0.17 | +23.5% | -Est: $24.3M | -100.0% |  10-Q |
| Aug 7, 2025 | Q2 2025 | -$0.16Est: -$0.17 | +5.9% | -Est: $2.6M | -100.0% | 10-Q |
| May 14, 2025 | Q1 2025 | -$0.17Est: -$0.24 | +29.2% | - | — | 10-Q |
| Feb 28, 2025 | Q4 2024 | -$0.27Est: -$0.22 | -22.7% | - | — | 10-K/A |
| Nov 7, 2024 | Q3 2024 | -$0.25Est: -$0.25 | 0.0% | - | — | 10-Q |
| Aug 1, 2024 | Q2 2024 | -$0.28Est: -$0.15 | -86.7% | - | — | 10-Q |
| May 2, 2024 | Q1 2024 | -$0.14Est: -$0.14 | 0.0% | - | — | 10-Q |
| Mar 7, 2024 | Q4 2023 | -$0.08Est: -$0.14 | +42.9% | -Est: $1.9M | -100.0% | 10-K |
| Nov 3, 2023 | Q3 2023 | -$0.14Est: -$0.24 | +41.7% | - | — | — |
| Aug 3, 2023 | Q2 2023 | -$0.15Est: -$0.31 | +51.6% | - | — | — |
| May 4, 2023 | Q1 2023 | -$0.27Est: -$0.29 | +6.9% | - | — | — |
| Mar 9, 2023 | Q4 2022 | -$0.22Est: -$0.31 | +29.0% | - | — | — |